Knee News and Research

RSS

CombinatoRx announces Synavive Phase 2 extension trial results at the 2009 ACR meeting

CombinatoRx, Incorporated today announced the results of a 12 month knee osteoarthritis (OA) Phase 2 extension trial for Synavive™ (CRx-102) at the American College of Rheumatology (ACR) 2009 Annual Meeting in Philadelphia. The data demonstrated that Synavive-treated subjects maintained efficacy levels throughout the 12 month extension trial.

21 Oct 2009

Assets of Cartilix acquired by Biomet

Biomet, Inc., a global leader in the manufacture of orthopedic and dental medical devices, announced today its acquisition of the assets of Cartilix, a Foster City, CA based company that has developed proprietary cartilage repair technology.

21 Oct 2009

NicOx presents data on its phase 3 naproxcinod study at the ACR meeting

NicOx S.A. announced the presentation of detailed 26-week efficacy, safety and tolerability data from the second pivotal phase 3 study for naproxcinod (the 302 study) yesterday, at the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.

20 Oct 2009

Lower extremity injuries on the rise among skiers

Over the last two decades, knee injuries have been on the rise among skiers in the French Alps. It is more likely for downhill skiers to experience a lower extremity injury than any other type of injury, whether due to a fall or a collision.

20 Oct 2009

Oral salmon calcitonin using absorption-enhancing Eligen Technology holds promise for osteoarthritis

Emisphere Technologies, Inc. announced study results in which twice-daily oral salmon calcitonin using Emisphere’s proprietary Eligen® Drug Delivery Technology significantly suppressed markers of cartilage and bone degradation versus placebo in men and women with osteoarthritis, the most common form of arthritis.

19 Oct 2009

Rich Plasma and Stem Cell therapies improve orthopedic conditions

Although stem cells sounds innovative and cutting edge, this therapy has been around for quite some time. In today's advanced medical climate stem cells are being used to treat many orthopedic conditions including osteoarthritis of the hip knee and shoulder, partial tears of tendons, muscles, and ligaments including rotator cuff tears, and various back conditions including disc herniations.

19 Oct 2009

Lubricin injections can reduce cartilage degeneration

Medical researchers will report findings today (Oct. 19) that demonstrate that injecting the protein lubricin into knee joints can dramatically reduce cartilage degeneration.

19 Oct 2009

Orthopedic device industry rattled by proposed tax

Kaiser Health News staff writer Julie Appleby, in partnership with USA Today, explores the impact health reform proposals could have on one part of the orthopedic device industry.

15 Oct 2009

Good Samaritan Hospital tops HealthGrade ratings for stroke treatment and joint replacement

A study issued today by HealthGrades, Inc., the leading independent healthcare ratings organization, finds that Good Samaritan Hospital is among the Top 5% in the Nation for Treatment of Stroke and Top 10% in the Nation for Joint Replacement. The nation’s nearly 5,000 nonfederal hospitals were all included in the sweeping study, which examined mortality rates and complication rates from government data from 2006, 2007 and 2008.

13 Oct 2009

Campaign to address rising health care costs

What if you could not find the price for anything at the grocery store, even the most basic items? What if the check-out clerk offered to mail you a bill, but could not tell you what your total amount would be?

13 Oct 2009

Patient outcomes better in highly rated hospitals than others

The largest annual study of patient outcomes at each of the nation's 5,000 nonfederal hospitals found a wide gap in quality between the nation's best hospitals and all others. According to the study, issued today by HealthGrades, the leading independent healthcare ratings organization, patients at highly rated hospitals have a 52 percent lower chance of dying compared with the U.S. hospital average, a quality chasm that has persisted for the last decade even as mortality rates, in general, have declined.

13 Oct 2009

Strengthen key muscles in the foot to improve overall performance

With summer weather finally gone, more Canadians will spend hours at the gym sculpting their muscles, but most will neglect one of the most important ones - the foot. Recent studies show neglecting the feet leads to chronic foot, knee, back, and joint pain. By strengthening key muscles in the foot, a person can improve their overall performance, energy and pain.

13 Oct 2009

Doctors and scientists form national pain research centre

An expert network of doctors and research scientists is forming the world's first national centre for research into understanding pain in arthritis. Backed by medical research charity the Arthritis Research Campaign and The University of Nottingham, it will aim to improve treatments for arthritis - the most common cause of chronic pain - which affects more than ten million people in the UK.

12 Oct 2009

First-quarter fiscal 2010 results announced by Biomet

Biomet, Inc. announced today financial results for its first fiscal quarter ended August 31, 2009.

9 Oct 2009

New England Donor Registry launched by Donate Life

Donate Life New England, a joint project of two federally designated organ procurement organizations that serve New England, today announced that individuals can now – for the first time – enroll online in the New England Donor Registry at www.donatelifenewengland.org.

8 Oct 2009

Electrostimulation techniques for osteoarthritis still unclear

Despite twenty years of research on the use of electrostimulation techniques (TENS) for treatment of osteoarthritis in the knee, researchers still cannot say whether it reduces pain or physical disability. This is the conclusion of a Cochrane Systematic Review of electrostimulation trials in osteoarthritis

7 Oct 2009

Patients and surgeons drive demand for elective orthopedic procedures despite economic slowdown

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, patients and surgeons are driving demand for elective orthopedic procedures.

7 Oct 2009

Opioid drugs may not be effective for osteoarthritis

Should you take opioid drugs for hip and knee pain caused by osteoarthritis? Probably not, suggests a new review of the best research on the subject.

7 Oct 2009

Younger patients have increased risk for additional ACL surgery

Anterior cruciate ligament (ACL) injuries are one of the most common injuries to the knee. Each year thousands of patients undergo reconstructive surgery to repair these injuries. According to a new study published in the October 2009 issue of The Journal of Bone and Joint Surgery (JBJS), the number of patients undergoing ACL reconstruction is increasing substantially and women and younger patients are more likely to need subsequent knee surgery following the initial repair.

5 Oct 2009

6.5 percent of ACL reconstruction patients undergo second knee surgery

Patients who have their anterior cruciate ligament (ACL) reconstructed are more likely to have subsequent knee surgery if they are women or are treated by a surgeon who does a low volume of ACL reconstructions, according to a study in the October 2009 TK issue of The Journal of Bone and Joint Surgery. The study, conducted by investigators at Hospital for Special Surgery, also found that overall, 6.5% of patients undergoing ACL surgery had to undergo another knee operation within one year.

3 Oct 2009